Mast cell activation syndrome: Proposed diagnostic criteria

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 6, 2010, Pages

  Akin, Cem ^a   Valent, Peter ^b   Metcalfe, Dean D ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

allergy; anaphylaxis; histamine; Mast cells; mastocytosis; tryptase; urticaria

Indexed keywords

STEM CELL FACTOR;

ALLERGY; CELL PROLIFERATION; DISEASE ASSOCIATION; HUMAN; IDIOPATHIC DISEASE; MAST CELL; MAST CELL ACTIVATION SYNDROME; MASTOCYTOSIS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; URTICARIA PIGMENTOSA;

EID: 78649824848     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.08.035     Document Type: Article

References (28)

1. The Mastocytosis Society. What are the symptoms of mast cell diseases?. Available at: http://www.tmsforacure.org/mastocytosis.shtml. Accessed December 21, 2009.
2. G.J. Molderings, U.W. Kolck, C. Scheurlen, M. Bruss, J. Homann, and I.V. Kugelgen Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder Scand J Gastroenterol 42 2007 1045 1053
3. L.J. Roberts Carcinoid syndrome and disorders of systemic mast-cell activation including systemic mastocytosis Endocrinol Metab Clin North Am 17 1988 415 436
4. D.D. Metcalfe Classification and diagnosis of mastocytosis: current status J Invest Dermatol 96 1991 2S 4S
5. J.M. Keffer, R.B. Bressler, R. Wright, M.A. Kaliner, and D.D. Metcalfe Analysis of the wheal and flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent, unexplained anaphylaxis and systemic mastocytosis J Allergy Clin Immunol 83 1989 595 601
6. J.L. Roberts, and J.A. Oates Biochemical diagnosis of systemic mast cell disorders J Invest Dermatol 96 1991 19S 25S
7. H.-P. Horny, D.D. Metcalfe, J.M. Bennett, B.J. Bain, C. Akin, and L. Escribano Mastocytosis S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffee, S.A. Pileri, H. Stein, WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Press Lyon 54 63
8. P. Valent, C. Akin, L. Escribano, M. Fodinger, K. Hartman, and D.D. Metcalfe Standards and standardization in mastocytosis: consensus statement on diagnostics, treatment recommendations and response criteria Eur J Clin Invest 37 2007 435 453
9. K. Brockow, C. Jofer, H. Behrendt, and J. Ring Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients Allergy 63 2008 226 232
10. C. Akin, L.M. Scott, C.N. Kocabas, N. Kushnir-Sukhov, E. Brittain, and P. Noel Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "Idiopathic" anaphylaxis Blood 110 2007 2331 2333
11. S. Iwaki, J. Spicka, C. Tkaczyk, B.M. Jensen, Y. Furumoto, and N. Charles Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells Cell Signal 20 2008 195 205
12. K. Sonneck, S. Florian, L. Mllauer, F. Wimazal, M. Födinger, and W.R. Sperr Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome Int Arch Allergy Immunol 142 2007 158 164
13. D. Ludolph-Hauser, F. Rueff, C. Fries, P. Schopf, and B. Przybilla Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings Lancet 357 2001 361 362
14. D. Gonzalez de Olano, I. Alverez-Twose, M.I. Esteban-Lopez, L. Sanchez- Munoz, M.D. de Durana, and A. Vega Safety and Effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis J Allergy Clin Immunol 121 2008 519 526
15. P. Bonadonna, O. Perbellini, G. Passalacqua, B. Caruso, S. Colarossi, and D. Dal Fior Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels J Allergy Clin Immunol 123 2009 680 686
16. D.D. Metcalfe Mast cell and mastocytosis Blood 12 2008 946 956
17. H. Nagata, A.S. Worobec, C.K. Oh, B.A. Chowdhury, S. Tannenbaum, and Y. Suzuki Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder Proc Natl Acad Sci U S A 92 1995 10560 10564
18. J. Gotlib, and J. Cools Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias Leukemia 22 2008 1999 2010
19. J.M. Brown, T.M. Wilson, and D.D. Metcalfe The mast cell and allergic diseases: role in pathogenesis and implications for therapy Clin Exp Allergy 38 2007 4 18
20. M.R. Woolhiser, K. Brockow, and D.D. Metcalfe Activation of human mast cells by aggregated IgG through FcγR1: effects of C3a Clin Immunol 119 2004 172 180
21. M. Kulka, L. Alexopoulou, R.A. Flavell, and D.D. Metcalfe Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor-3 (TLR-3) J Allergy Clin Immunol 114 2004 174 182
22. H.A. Sampson, A. Muñoz-Furlong, S.A. Bock, S. Schmitt, R. Bass, and B.A. Chowdhury Symposium on the definition and management of anaphylaxis: summary report J Allergy Clin Immunol 115 2005 584 591
23. H.A. Sampson, A. Muñoz-Furlong, R.L. Campbell, N.F. Adkinson, S.A. Bock, and A. Branum Second symposium on the definition and management of anaphylaxis: Summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium J Allergy Clin Immunol 117 2006 391 397
24. W.R. Sperr, A. El-Samahi, M. Kundi, M. Girschikofsky, S. Winkler, and D. Lutz Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology Eur J Clin Invest 39 2009 914 923
25. D. Kassab, A. Koterba, Y. Jiang, and C. Akin Elevated tryptase levels in patients with mast cell activation syndromes without evidence of mastocytosis J Allergy Clin Immunol 121 suppl 2008 S67
26. I. Álvarez-Twose, D. González de Olano, L. Sánchez-Muñoz, A. Matito, M. Esteban-López, and A. Vega Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation syndrome J Allergy Clin Immunol 125 2010 1269 1278 e2
27. A.M. Dvorak ultrastructure of mast cells and basophils J. Ring, L. Adorini, C. Berek, K. Blaser, M. Capron, J.A. Denburg, Chemical immunology and allergy vol. 85 2005 Karger Basel 135 184
28. A.L. Sheffer, A.K. Tong, G.F. Murphy, R.A. Lewis, E.R. McFadden Jr., and K.F. Austen Exercise-induced anaphylaxis: a serious form of physical allergy associated with mast cell degranulation J Allergy Clin Immunol 75 1985 479 484